← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 27, 2020Last known activity
Feb 15, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (2)
- NCT05212480Overall official - principal investigatorN/AFeb 15, 2022
- NCT04597775CollaboratorPhase 2/Phase 3Oct 27, 2020
Details
- Last known activity
- Feb 15, 2022